Melanoma CME

This activity is expired and is no longer available for CME credit.


Toward Precision Medicine for Advanced Melanoma Management: Making the Most of Targeted Agents

Author(s)/Faculty: Axel Hauschild, MD; Grant McArthur, MBBS, BMedSci, PhD, FRACP
Release Date: 1/26/2017Expiration Date: 1/12/2019
Credit Type: CMENumber of Credits: 0
Content Type: LectureProvider:
The identification and utilization of melanoma specific biomarkers continues to be of importance for diagnosis and prognosis, and the selection of tailored therapy. Common somatic mutations in melanoma have been utilized to predict response to targeted therapy leading to improved clinical outcomes in patients with advanced disease. As targeted treatment strategies continue to evolve, it is essential that clinicians caring for patients with advanced melanoma are familiar with recent clinical advances, current and emerging biomarkers, and effective treatment strategies. Within this CME activity, Dr. Grant McArthur discusses Precision Medicine in Melanoma: Advances in Knowledge of Biomarkers and Targeted Therapies.